VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_20-vv-01882 Package ID: USCOURTS-cofc-1_20-vv-01882 Petitioner: Kelly Joyce Filed: 2020-12-16 Decided: 2024-03-22 Vaccine: influenza Vaccination date: 2019-11-08 Condition: left shoulder injury related to vaccine administration (SIRVA) Outcome: compensated Award amount USD: 1569302 AI-assisted case summary: Kelly Joyce filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging she suffered a left shoulder injury related to vaccine administration (SIRVA) after receiving an influenza vaccine on November 8, 2019. The vaccine record did not specify the vaccination site, but the court determined that the flu vaccine was most likely administered in her left shoulder and that her pain onset occurred within 48 hours of vaccination. Respondent conceded that Petitioner had met the requirements for a Table SIRVA and was entitled to compensation. The case proceeded to a damages hearing. The court awarded Kelly Joyce $1,569,302.82, reflecting $1,325,375.00 for past and future lost wages, $215,000.00 for past pain and suffering, $26,063.60 for future pain and suffering, and $2,864.22 for past unreimbursed expenses. This award was based on the parties' agreement on most damages and the court's determination of the net present value of future pain and suffering, considering the statutory cap. Theory of causation field: Table Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_20-vv-01882-0 Date issued/filed: 2022-01-18 Pages: 8 Docket text: PUBLIC ORDER/RULING (Originally filed: 12/14/2021) regarding 26 Findings of Fact & Conclusions of Law, Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 1 of 8 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1882V UNPUBLISHED KELLY JOYCE, Chief Special Master Corcoran Petitioner, Filed: December 14, 2021 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Findings of Fact; Site of Vaccination HUMAN SERVICES, Influenza (Flu) Vaccine; Shoulder Injury Related to Vaccine Respondent. Administration (SIRVA) Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner. Nancy Tinch, U.S. Department of Justice, Washington, DC, for Respondent. FINDINGS OF FACT1 On December 16, 2020, Kelly Joyce filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to vaccine administration (“SIRVA”), a defined Table injury, after receiving an influenza (“flu”) vaccine on November 8, 2019. Petition at 1, ¶¶ 4, 38-39. Petitioner further alleges that her SIRVA was caused-in-fact by the flu vaccine she received. Id. at ¶¶ 38, 40. Acknowledging that the vaccine record does not indicate the site of administration, Petitioner nevertheless maintains there is preponderant evidence to establish the vaccine 1 Because this unpublished Fact Ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E- Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Fact Ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 2 of 8 was administered in her left shoulder as alleged. Id. at ¶ 4. The case was assigned to the Special Processing Unit of the Office of Special Masters. For the reasons discussed below, I find the flu vaccine was most likely administered in Petitioner’s left shoulder, as alleged, and that onset of Petitioner’s pain occurred within 48 hours of vaccination. I. Relevant Procedural History The day after she filed the Petition, Ms. Joyce filed an affidavit and most of the medical records required under the Vaccine Act. Exhibits 1-16, ECF No. 6; see Section 11(c). Over the subsequent seven-month period, she filed additional prior and updated medical records. Exhibits 17-24, ECF Nos. 11-14, 16-17. Petitioner also filed a status report citing entries in her medical records which, she argues, show she received the November 8, 2019 vaccine in her left shoulder as alleged. Status Report, filed July 19, 2021, ECF No. 18. On September 21, 2021, Respondent filed a status report indicating that “[a]t this time, Respondent’s counsel does not wish to file briefing regarding the site of vaccination.” Status Report, ECF No. 21. In October and November 2021, Petitioner filed additional medical records including a copy of her worker’s compensation settlement agreement. Exhibits 25-30, ECF Nos. 22, 24-25. Petitioner also filed a status report reiterating her request for a fact ruling regarding the site of vaccination and disagreeing with Respondent’s assertion that I should delay this factual determination until the HHS review is completed. ECF No. 23. Given the current backlog of vaccine cases awaiting the HHS review which has existed for several years, I have consistently encouraged the parties to vaccine injury cases to identify and address factual issues which do not require medical expertise, and thus can be decided prior to the HHS review. The factual issue regarding vaccine administration situs in this case fits squarely in that category. For the sake of judicial efficiency, I will simultaneously address the issue of the onset of Petitioner’s pain. These issues are now ripe for adjudication. II. Issue At issue is whether (a) Petitioner received the vaccination alleged as causal in his injured left arm, and (b) Petitioner’s first symptom or manifestation of onset after vaccine administration (specifically pain) occurred within 48 hours as required in the Vaccine Injury Table and Qualifications and Aids to Interpretation (“QAI”) for a Table SIRVA. 42 2 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 3 of 8 C.F.R. § 100.3(a) XIV.B. (2017) (Table entry for SIRVA following the influenza vaccination); 42 C.F.R. § 100.3(c)(10)(ii) (required onset for pain listed in the QAI). III. Authority Pursuant to Vaccine Act Section 13(a)(1)(A), a petitioner must prove, by a preponderance of the evidence, the matters required in the petition by Section 11(c)(1). A special master must consider, but is not bound by, any diagnosis, conclusion, judgment, test result, report, or summary concerning the nature, causation, and aggravation of petitioner’s injury or illness that is contained in a medical record. Section 13(b)(1). “Medical records, in general, warrant consideration as trustworthy evidence. The records contain information supplied to or by health professionals to facilitate diagnosis and treatment of medical conditions. With proper treatment hanging in the balance, accuracy has an extra premium. These records are also generally contemporaneous to the medical events.” Cucuras v. Sec’y of Health & Human Servs., 993 F.2d 1525, 1528 (Fed. Cir. 1993). Accordingly, where medical records are clear, consistent, and complete, they should be afforded substantial weight. Lowrie v. Sec’y of Health & Human Servs., No. 03- 1585V, 2005 WL 6117475, at *20 (Fed. Cl. Spec. Mstr. Dec. 12, 2005). However, this rule does not always apply. In Lowrie, the special master wrote that “written records which are, themselves, inconsistent, should be accorded less deference than those which are internally consistent.” Lowrie, 2005 WL 6117475, at *19. The United States Court of Federal Claims has recognized that “medical records may be incomplete or inaccurate.” Camery v. Sec’y of Health & Human Servs., 42 Fed. Cl. 381, 391 (1998). The Court later outlined four possible explanations for inconsistencies between contemporaneously created medical records and later testimony: (1) a person’s failure to recount to the medical professional everything that happened during the relevant time period; (2) the medical professional’s failure to document everything reported to her or him; (3) a person’s faulty recollection of the events when presenting testimony; or (4) a person’s purposeful recounting of symptoms that did not exist. La Londe v. Sec’y of Health & Human Servs., 110 Fed. Cl. 184, 203-04 (2013), aff’d, 746 F.3d 1335 (Fed. Cir. 2014). The Court has also said that medical records may be outweighed by testimony that is given later in time that is “consistent, clear, cogent, and compelling.” Camery, 42 Fed. Cl. at 391 (citing Blutstein v. Sec’y of Health & Human Servs., No. 90-2808, 1998 WL 408611, at *5 (Fed. Cl. Spec. Mstr. June 30, 1998). The credibility of the individual offering such testimony must also be determined. Andreu v. Sec’y of Health & Human Servs., 569 3 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 4 of 8 F.3d 1367, 1379 (Fed. Cir. 2009); Bradley v. Sec’y of Health & Human Servs., 991 F.2d 1570, 1575 (Fed. Cir. 1993). The special master is obligated to fully consider and compare the medical records, testimony, and all other “relevant and reliable evidence contained in the record.” La Londe, 110 Fed. Cl. at 204 (citing Section 12(d)(3); Vaccine Rule 8); see also Burns v. Sec’y of Health & Human Servs., 3 F.3d 415, 417 (Fed. Cir. 1993) (holding that it is within the special master’s discretion to determine whether to afford greater weight to medical records or to other evidence, such as oral testimony surrounding the events in question that was given at a later date, provided that such determination is rational). IV. Finding of Fact I make the following findings regarding site of vaccination and onset after a complete review of the record, including medical records, affidavits, and other additional evidence filed showing: • The vaccine record indicates Petitioner received a flu vaccine on November 8, 2019, at her placement of employment - Tufts Medical Center. Exhibit 2 at 4. The method and site of vaccination are not indicated. Id. Email exchanges between Petitioner’s counsel and personnel at Tufts Medical Center indicate the site of vaccination is not recorded in the electronic database. Id. at 1-3. • In her affidavit, Petitioner alleged that she received the flu vaccine in her left, non-dominant shoulder. Exhibit 3 at ¶ 3. She added that she “always received [her] annual flu shot in [her] non-dominant left arm, and . . . specifically recall[ed] that [she] received the November 8, 2019 flu shot in [her] left shoulder.” Id. Petitioner described pain which began a few hours after vaccination and increased to a severe level which prevented her from performing her duties as a nurse. Id. at ¶ 5. • Six days post-vaccination, on the morning of November 14, 2019, Petitioner sought medical care from a provider at Tufts Medical Center, Dr. John Doyle. Exhibit 4 at 12. The description she provided at this visit – of left shoulder pain which began several hours after vaccination and which gradually increased until severe – matches the assertions in Petitioner’s affidavit. Petitioner was referred to the orthopedic clinic and excused from work until re-evaluated. Id. 4 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 5 of 8 • At her orthopedic appointment that same day, Petitioner complained of “left shoulder pain after receiving a flu shot on 11/8/19.” Exhibit 4 at 38 (November 14, 2019 orthopedic visit). She indicated that she returned to work post-vaccination and did not recall any complications until the next day. Id. Upon examination, the orthopedist, Dr. Charles Cassidy observed no swelling, warmth, or tenderness upon palpitation. He diagnosed Petitioner with biceps tendonitis, “likely due to inflammation around her biceps tendon.” Id. at 40. • The next day on November 15, 2019, Petitioner completed an Employee Incident Report regarding a flu shot injury to her left arm. Exhibit 4 at 117. • On November 18, 2019, Petitioner returned for a follow-up appointment with Dr. Doyle. Exhibit 4 at 13. Relaying Dr. Cassidy’s opinion – that there was not an infectious process occurring and that the pain was due to biceps tendonitis, Petitioner described sharp pain with certain movements. Dr. Doyle excused Petitioner from work for the rest of the week. Id. • When seen again at the orthopedic clinic on November 25, 2019, Petitioner again reported severe pain which began the day after her November 8, 2019 vaccination. Exhibit 5 at 14. Dr. Cassidy diagnosed Petitioner with adhesive capsulitis and discussed treatment options. Petitioner opted for physical therapy (“PT”). Id. at 16. • Following this November 25, 2019 orthopedic visit, Petitioner provided a telephone update to Dr. Doyle. Exhibit 4 at 13. She indicated she would contact the local PT office and would provide another update on December 2, 2018. In this record, it was noted that Petitioner had declined a steroid injection. Id. • When seen again by Dr. Doyle at 8:10AM on December 2, 2019, Petitioner expressed an interest in receiving a steroid injection from Dr. Cassidy, who she believed was seeing patients that day. Exhibit 4 at 14. • Later that day, Dr. Cassidy provided the requested steroid injection. Exhibit 4 at 32. He noted that Petitioner “continues to have vague shoulder symptoms following a flu vaccination . . . [but] symptoms [which were] not consistent with any one diagnosis.” Id. He assessed Petitioner as having “[s]ubacromial impingement of [the] left shoulder.” Id. 5 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 6 of 8 • During her first PT session from 1:00PM until 2:00PM on December 2, 2019, Petitioner again reported left shoulder pain and frozen shoulder due to the administration of the flu vaccine on November 8, 2019. Exhibit 6 at 8. Attending a total of four PT sessions in December 2019 and failing to return thereafter, Petitioner was discharged on April 6, 2020. Exhibit 6 at 12-19. • When treated by Dr. Doyle on December 9, 2019, Petitioner reported slight improvement following the cortisone injection and PT. Exhibit 4 at 14. She was excused from work for the remainder of the week. Id. • Seen again by Dr. Cassidy on January 6, 2020, it was noted that Petitioner’s injury was most consistent with adhesive capsulitis, but that she was recovering faster than expected given the nature of her disease. Exhibit 4 at 28. • Petitioner provided another telephone update to Dr. Doyle on January 14, 2020, indicating she continued to have left shoulder pain and difficulties with certain movements. Exhibit 4 at 16. She was instructed to continue PT and remain at home. Id. • At her next appointment with Dr. Doyle on January 28, 2020, Petitioner continued to report left shoulder pain and difficulties performing certain tasks. Exhibit 4 at 17. • On February 7, 2020, Petitioner underwent an MRI. Exhibit 4 at 23. She again reported “left shoulder pain post-vaccination.” Id. The MRI revealed “[f]ull-thickness tear of the anterior supraspinatus . . . with moderate underlying tendinosis, . . . [p]robable focal tear of the anterior labrum, . . . [m]arked fluid within the subacromial subdeltoid bursa.” Id. • Petitioner has provided the documentation connected to her worker’s compensation claim which includes an April 13, 2020 email from Dr. Todd M. O’Brien and an August 6, 2020 letter from Dr. David C. Morley, Jr., communicating both physician’s opinions that Petitioner’s left shoulder injury was due to the flu vaccine she received on November 8, 2019. Exhibit 15 at 1-2 (Dr. O’Brien’s email); Exhibit 11 at 4-6 (Dr. O’Brien’s letter). In every post-vaccination record containing a medical history, from the time she first sought treatment on November 14, 2019 (only six days post-vaccination), Petitioner consistently described left shoulder pain as beginning a few hours post-vaccination, 6 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 7 of 8 increasing thereafter to a severe level which interfered with her ability to work by the next day. Without fail, she attributed her injury to the flu vaccine she received on November 8, 2019. Petitioner provided extremely consistent accounts of her injury and the onset of her pain. While these entries were based upon information provided by Petitioner, they still should be afforded greater weight than more current representations, as they were uttered contemporaneously with Petitioner’s injury for the purposes of obtaining medical care. The Federal Circuit has stated that “[m]edical records, in general, warrant consideration as trustworthy evidence . . . [as they] contain information supplied to or by health professionals to facilitate diagnosis and treatment of medical conditions.” Cucuras, 993 F.2d at 1528 (emphasis added). Thus, the Circuit has instructed that greater weight should be accorded to this information even when the information is provided by Petitioner.3 The vaccine record clearly supports Petitioner’s claims of receiving the flu vaccine in her left arm on November 8, 2019, and experiencing left shoulder pain within 48 hours thereafter. There is nothing in the vaccine record or medical records in this case to indicate administration was in Petitioner’s other arm (right) or that the onset of Petitioner’s pain was not within 48 hours as Petitioner consistently reported. And the fact that situs is not itself corroborated by a medical record does not rebut the combination of Petitioner’s contemporaneous reports to treaters of a left-shoulder vaccination and her own witness statements. Thus, I find there is preponderant evidence to establish the vaccination alleged as causal in this case was administered to Petitioner in the left deltoid, and that onset of Petitioner’s pain occurred within 48 hours of vaccination. V. Scheduling Order Based on recent data, I expect the HHS review to be completed in this case in February 2022. In the meantime, it is appropriate for Petitioner to forward a demand and supporting documentation to Respondent prior to the HHS review.Thus, Petitioner should finalize her demand which she may forward to Respondent, along with her supporting documentation, at any time. 3 Additionally, Petitioner has provided evidence, related to Petitioner’s worker’s compensation claim, that two different physicians concluded her injury was due to the flu vaccine she received on November 8, 2019. It would be illogical for these physicians to have reached this conclusion absent a belief that Petitioner received the vaccine in question in her left, injured arm (although that belief does not independently establish situs). 7 Case 1:20-vv-01882-UNJ Document 28 Filed 01/18/22 Page 8 of 8 Petitioner shall file a status report indicating the date by which she conveyed or expects to convey her demand and supporting documentation to Respondent by no later than Friday, January 14, 2022. Respondent shall file a status report indicating how he intends to proceed by no later than Tuesday, February 15, 2022. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 8 ================================================================================ DOCUMENT 2: USCOURTS-cofc-1_20-vv-01882-1 Date issued/filed: 2022-06-16 Pages: 2 Docket text: PUBLIC ORDER/RULING (Originally filed: 05/03/2022) regarding 39 Ruling on Entitlement Signed by Chief Special Master Brian H. Corcoran. (sw) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-01882-UNJ Document 43 Filed 06/16/22 Page 1 of 2 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1882V UNPUBLISHED KELLY JOYCE, Chief Special Master Corcoran Petitioner, Filed: May 3, 2022 v. Special Processing Unit (SPU); SECRETARY OF HEALTH AND Ruling on Entitlement; Concession; HUMAN SERVICES, Table Injury; Influenza (Flu) Vaccine; Shoulder Injury Related to Vaccine Respondent. Administration (SIRVA) Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner. Nancy Tinch, U.S. Department of Justice, Washington, DC, for Respondent. RULING ON ENTITLEMENT1 On December 16, 2020, Kelly Joyce filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to vaccine administration (“SIRVA”), a defined Table injury, after receiving an influenza (“flu”) vaccine on November 8, 2019. Petition at 1, ¶¶ 4, 38-39. Petitioner further alleges that her SIRVA was caused-in-fact by the flu vaccine she received, that she received the vaccine in the United States, that she suffered the residual effects of her SIRVA for more than six months, and that neither she nor any other party has filed a civil case or received 1 Because this unpublished Ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). Case 1:20-vv-01882-UNJ Document 43 Filed 06/16/22 Page 2 of 2 compensation for her SIRVA injury. Id. at ¶¶ 4, 38, 40, 42-44. The case was assigned to the Special Processing Unit of the Office of Special Masters. Because the vaccine record in this case did not indicate the site of vaccination,3 I issued a fact ruling on December 14, 2021, finding the flu vaccine was most likely administered in Petitioner’s left shoulder, as alleged, and that onset of Petitioner’s pain occurred within 48 hours of vaccination. ECF No. 26. Thereafter, Respondent filed a Rule 4(c) Report recommending compensation be awarded in this case. Rule 4(c) Report at 1, ECF No. 38. Reserving his right to appeal my fact ruling (id. at 12-13) and based upon my factual findings and the record as it currently stands, Respondent “has concluded that [P]etitioner suffered SIRVA as defined by the Vaccine Injury Table.” Id. at 13. Furthermore, he “does not dispute that that [P]etitioner has satisfied all legal prerequisites for compensation under the Act.” Id. In view of Respondent’s position and the evidence of record, I find that Petitioner is entitled to compensation. IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 In her petition, Ms. Joyce also acknowledges that the vaccine record does not indicate the site of administration. Petition at ¶ 4; see Exhibit 2 at 4 (vaccine record). 2 ================================================================================ DOCUMENT 3: USCOURTS-cofc-1_20-vv-01882-2 Date issued/filed: 2023-10-16 Pages: 3 Docket text: PUBLIC ORDER/RULING (Originally filed: 09/12/2023) regarding 77 Scheduling Order, Findings of Fact & Conclusions of Law. Signed by Chief Special Master Brian H. Corcoran. (kle) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-01882-UNJ Document 83 Filed 10/16/23 Page 1 of 3 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1882V KELLY JOYCE, Chief Special Master Corcoran Petitioner, Filed: September 12, 2023 v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner. Ryan Daniel Pyles, U.S. Department of Justice, Washington, DC, for Respondent. RULING ON DAMAGES1 On December 16, 2020, Kelly Joyce filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleges that she suffered a left shoulder injury related to vaccine administration (“SIRVA”), a defined Table injury, after receiving an influenza (“flu”) vaccine on November 8, 2019. Petition at 1, ¶¶ 4, 38-39. On May 3, 2022, I issued a ruling on entitlement, finding Petitioner entitled to compensation. Because the parties could not informally resolve the issue of damages, I allowed the retention of vocational experts, 1 Because this Ruling contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018). Case 1:20-vv-01882-UNJ Document 83 Filed 10/16/23 Page 2 of 3 ordered the parties to file briefs setting forth their respective arguments, and held a damages hearing on September 11, 2023. Petitioner seeks $225,000.00 for past pain and suffering, $2,500 per year for the remainder of her life for future pain and suffering, $2,864.22 for past unreimbursed expenses, and an undetermined amount for past and future lost wages. Respondent recommends an award of $165,000.00 for past pain and suffering. Regarding the other types of compensation sought by Petitioner, he maintains there is insufficient evidence to support the amounts claimed. After listening to the testimony provided by Petitioner, her spouse, and the parties’ vocational experts, I issued an oral ruling on the compensation to be awarded for Petitioner’s past and future pain and suffering and past unreimbursable expenses. I also provided guidance related to past and future lost wages and set deadlines for expert reports from the parties’ economists. An official recording of the proceeding was taken by a court reporter, although a transcript has not yet been filed in this matter. I hereby fully adopt and incorporate that oral ruling as officially recorded. Based on my consideration of the complete record as a whole and for the reasons discussed in my oral ruling, I find that $215,000.00 represents a fair and appropriate amount of compensation for Petitioner’s actual pain and suffering and $1,000.00 per year for life - reduced to net present value3, represents a fair and appropriate amount of compensation for Petitioner’s projected pain and suffering. I also find that Petitioner is entitled to $2,864.22 in actual unreimbursable expenses. Petitioner shall file her economist’s expert report, briefing, and additional evidence regarding actual and projected lost wages by no later than Monday, October 02, 2023. Respondent shall file his economist’s expert report and briefing regarding actual and projected lost wages by no later than Monday, October 31, 2022. Because the $250,000.00 statutory cap should be applied prior to the reduction of Petitioner’s projected pain and suffering award to net present value,4 the parties should provide proposed amounts for this compensation, including the discount rate applied. 3 Under the Vaccine Act, compensation payments are based upon the net present value of any award. Section 15(f)(4)(A). 4 Youngblood v. Sec’y of Health & Hum. Servs., 32 F.3d 552 (Fed. Cir. 1994)) (discussing the application of the requirements of Section 15(a)(4) and Section 15(f)(4)(A)). 2 Case 1:20-vv-01882-UNJ Document 83 Filed 10/16/23 Page 3 of 3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 ================================================================================ DOCUMENT 4: USCOURTS-cofc-1_20-vv-01882-3 Date issued/filed: 2024-03-22 Pages: 6 Docket text: PUBLIC DECISION (Originally filed: 02/20/2024) regarding 90 DECISION of Special Master. Signed by Chief Special Master Brian H. Corcoran. (kle) Service on parties made. -------------------------------------------------------------------------------- Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 1 of 6 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 20-1882V KELLY JOYCE, Chief Special Master Corcoran Petitioner, v. Filed: February 20, 2024 SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent. Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner. Ryan Daniel Pyles, U.S. Department of Justice, Washington, DC, for Respondent. DECISION AWARDING DAMAGES1 On December 16, 2020, Kelly Joyce filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.2 (the “Vaccine Act”). Petitioner alleged that she suffered a left shoulder injury related to vaccine administration (“SIRVA”), a defined Table injury or, in the alternative a causation-in-fact claim, after receiving an influenza (“flu”) vaccine on November 8, 2019. Petition at 1, ¶¶ 4, 38-40. For the reasons set forth below, incorporating the agreement of the parties on some issues, and consistent with my earlier ruling related to Petitioner’s pain and 1 Because this Decision contains a reasoned explanation for the action taken in this case, it must be made publicly accessible and will be posted on the United States Court of Federal Claims' website, and/or at https://www.govinfo.gov/app/collection/uscourts/national/cofc, in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2018) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all section references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2018). Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 2 of 6 suffering award and unreimbursed expenses,3 I find that Petitioner is entitled to an award of damages in the amount $1,569,302.82, reflecting $1,325,375.00 for past and future lost wages, $215,000.00 for past pain and suffering, $26,063.60 for future pain and suffering, and $2,864.22 for past unreimbursed expenses. I. Relevant Procedural History On December 17, 2020 (the day after this claim was initiated), Ms. Joyce filed the affidavit and medical records required by the Vaccine Act. Exhibits 1-16, ECF No. 6. On February 5, 2021, the case was activated and assigned to the Special Processing Unit (OSM’s process for attempting to resolve certain, likely-to-settle claims). ECF No. 8. Over the subsequent six-month period, Petitioner continued to file any updated medical records and relevant documentation. Exhibits 17-24. ECF Nos. 11-17. Because the vaccine record did not indicate the site of vaccination, after giving the parties the opportunity to provide additional evidence and briefing (ECF No. 20), I issued a fact ruling, determining the flu vaccine was most likely administered in Petitioner’s left shoulder, as alleged. See Joyce v. Sec’y of Health & Hum. Servs., No. 20-1882V, 2021 WL 6504389 (Fed. Cl. Spec. Mstr. Dec. 14, 2021) (ECF No. 26). For the sake of judicial efficiency, I simultaneously addressed the issue of the pain onset, finding it occurred within 48 hours. Id. at *1. Prior to and after I issued this ruling, Petitioner continued to provide additional updated medical records, including documentation from her workers’ compensation claim. Exhibits 25-34, ECF Nos. 22, 24-25, 29, 32, 34-35. On April 29, 2022, Respondent filed a Rule 4(c) Report, stating that, while reserving his right to appeal my situs and onset determinations, he believed that Petitioner had met the requirements for a Table SIRVA. ECF No. 38. Four days later, I issued a ruling, finding Petitioner entitled to compensation. ECF No. 39. During the subsequent six-month period, the parties attempted to informally resolve the issue of damages. See, e.g., Status Reports, filed July 14, 2022, ECF Nos. 45-46; Status Report, filed Oct. 19, 2022, ECF No. 56. Throughout this time, Petitioner continued to file updated medical records and documentation related to her claim for lost wages and unreimbursable expenses, including a report from Petitioner’s vocational expert. Exhibits 35-52, ECF Nos. 41, 44, 47, 52-53, 57. 3 Joyce v. Sec’y of Health & Hum. Servs., No. 20-1882V, 2023 WL 6811015 (Fed. Cl. Spec. Mstr. Sept. 12, 2023). 2 Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 3 of 6 On November 8, 2022, the parties informed me they were unable to reach an informal agreement and requested that I conduct a hearing to determine the appropriate amount of damages. ECF No. 59. Prior to the September 2023 hearing, Respondent filed his vocational expert’s report, and Petitioner filed additional updated medical records, other evidence, and a supplement report from her vocational expert. Exhibits A-B, ECF Nos. 60, 67; Exhibits 53-70, ECF Nos. 61-65, 68, 73, 75. Pre-hearing briefing revealed additional evidence and argument related to lost wages would be needed following the hearing. See Order, issued Aug. 23, 2023, ECF No. 74. At the damages hearing, conducted on September 11, 2023, I issued an oral ruling, finding Petitioner entitled to $215,000.00 for past pain and suffering, $1,000.00 per year for future pain and suffering, and $2,864.22 for past unreimbursed expenses. Joyce, 2023 WL 6811015, at *2 (ECF No. 77). I also provided guidance related to past and future lost wages and set deadlines for expert reports from the parties’ economists regarding that compensation, as well as the net present value of the future pain and suffering award. Id. During the subsequent three-month period, Petitioner filed two expert reports from his economist and a letter related to Petitioner’s workers’ compensation claim, and Respondent filed his economist’s expert report. See Exhibits 71-74, ECF Nos. 78-79, 86; Exhibit C, ECF No. 84. In their most recent briefs, the parties informed me they had agreed upon the appropriate amount of past and future lost wages ($1,325,375.00), and dispute only the appropriate net present value of the future pain and suffering award. Respondent’s Brief on Damages (“Res. Latest Brief”), filed Dec. 1, 2023, at 6, ECF No. 88; Petitioner’s Reply to Respondent’s Brief on Damages (“Pet. Latest Brief”), filed Dec. 1, 2023, at 1, ECF No. 89 (waiving her earlier request for compensation due to a loss of household services and accepting Respondent’s proposed amount of lost wages). II. Net Present Value of Projected Pain and Suffering Award Due to the Vaccine Act’s statutory cap of $250,000.00 for any pain and suffering award, which must be applied prior to the reduction of the portion attributable to future pain and suffering to its net present value,4 the future award in this case is limited to $35,000.00.5 The parties agree that, based upon Petitioner’s life expectancy, she would otherwise be entitled to a greater award. Res. Latest Brief at 5; Pet. Latest Brief at 2 n.1. 4 See Section 15(a)(4) (statutory limit for actual and projected pain and suffering); Section 15(f)(4)(A) (requirement regarding net present value for future compensation); Youngblood v. Sec’y of Health & Hum. Servs., 32 F.3d 552, 554-55 (Fed. Cir.1994) (requiring the application of the statutory cap before any projected pain and suffering award is reduced to net present value). 5 This amount is calculated by subtracting the amount awarded for Petitioner’s past pain and suffering, $215,000.00, from the statutory cap of $250,000.00. 3 Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 4 of 6 To reduce this amount to its net present value, Petitioner proposes that I apply the multipronged approach previously employed in Dillenbeck, which uses a discount rate of one-percent for the first fifteen years and two-percent thereafter, resulting in a future pain and suffering award of $26,063.60. Pet. Latest Brief at 1-2 (citing Dillenbeck v. Sec’y of Health & Hum. Servs, No. 17-0428V, 2019 WL 4072069, at *15 (Fed. Cl. Spec. Mstr. July 29, 2019)). Asserting that discount rates have historically ranged between one and three- percent, he insists that this approach already accounts for fluctuating treasury interest rates. Id. at 2 (citing Mulloy v. Sec’y of Health & Hum. Servs., No. 19-1396V, 2023 WL 2620653, at *10 (Fed. Cl. Spec. Mstr. Mar. 24, 2023)). Respondent counters that a two-percent discount rate for all years is more appropriate, resulting in a future pain and suffering award of $25,156.00. Res. Latest Brief at 6. Emphasizing that the ruling in Dillenbeck was based upon a decision which is more than seven years old (Neiman), he maintains that Dillenbeck “is objectively and patently outdated.” Id. (citing Dillenbeck, 2019 WL 4072069, at *15); see also Neiman v. Sec’y of Health & Hum. Servs., No. 15-0631V, 2016 WL 7741742 (Fed. Cl. Spec. Mstr. Oct. 31, 2016)). He stresses that the basis for applying the rates in Dillenbeck, historically low treasury rates, no longer applies. Res. Latest Brief at 6. To further support his position, Respondent cites the report from his economist, Patrick F. Kennedy, Ph.D., which contains a detailed section regarding the appropriate discount rate to be used when calculating the net present value of the future lost wages award. Res. Latest Brief at 5 (citing Exhibit C at 8). As Dr. Kennedy explains, the appropriate discount rate to be used during this calculation is based upon two factors: 1) the growth in future wages and 2) the interest a lump sum award will earn over time. Exhibit C at 8. Based upon economic projections which show the current higher interest and inflation rates are expected to decrease moderately in 2025 and 2026, Dr Kennedy concluded the second criteria (a factor relevant to all future awards) translates to a discount rate of 1.5 percent. He further reduced the rate by .2 percent to account for wage growth (a factor relevant only to future lost wages compensation). Exhibit C at 8-14. And the parties have accepted these calculations. Although Dr. Kennedy utilized a two percent discount rate when calculating the net present value of the future pain and suffering award, he clearly states that he is doing so at Respondent’s direction. Exhibit C at 8. If I instead used a discount rate 1.5 percent (as was accepted for the lost wages reduction), without any modification for wage growth, the 4 Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 5 of 6 resulting amount would be $27,075.59,6 an amount greater than even Petitioner’s proposed amount. Thus, I find that Dr. Kennedy’s report offers only tepid support for the two-percent discount rate proposed by Respondent. Instead, it lends credence to Petitioner’s argument that the multipronged approach she proposes more properly accounts for rate fluctuations, although arguably the order of the rates should be reversed. I agree that the lower treasury rates which formed the basis of the multipronged approach Petitioner proposes no longer exist. However, as Dr. Kennedy opines, the current higher rates are unlikely to continue for more than a few years, certainly not for the 35-year period covered by the future pain and suffering award. Therefore, I find the amount proposed by Petitioner reflects a more accurate reflection of the appropriate net present value. Respondent has not provided sufficient evidence to warrant the use of the two-percent discount rate he proposes for the entire thirty five-year period. Conclusion For all of the reasons discussed above, I will adopt the net present value of Petitioner’s future pain and suffering proposed by Petitioner. Pursuant to my earlier ruling, I therefore award Petitioner $215,000.00 for actual pain and suffering, $26,063.60 for projected pain and suffering, and $2,864.22 for her actual unreimbursable expenses. Furthermore, I find the parties’ agreed upon amount of actual and projected lost wages, $1,325,375.00 is reasonable. Thus, I award Petitioner a lump sum payment of $1,569,302.82, representing $1,325,375.00 for actual and projected lost wages, $215,000.00 for actual pain and suffering, $26,063.60 for projected pain and suffering, and $2,864.22 for actual unreimbursable expenses in the form of a check payable to Petitioner. This amount represents compensation for all damages that would be available under Section 15(a). The clerk of the court is directed to enter judgment in accordance with this decision.7 6 This result is obtained when designating yearly payments beginning one year from the date of this Decision, compounding annually. See https://accuratecalculators.com/present-value-of-an-annuity- calculator (last visited Feb. 20, 2024). 7 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice renouncing the right to seek review. 5 Case 1:20-vv-01882-UNJ Document 96 Filed 03/22/24 Page 6 of 6 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 6